FMR LLC - GRITSTONE ONCOLOGY INC ownership

GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 94 filers reported holding GRITSTONE ONCOLOGY INC in Q3 2021. The put-call ratio across all filers is 1.95 and the average weighting 0.3%.

Quarter-by-quarter ownership
FMR LLC ownership history of GRITSTONE ONCOLOGY INC
ValueSharesWeighting
Q3 2023$1,468,189
-4.7%
853,598
+8.0%
0.00%
Q2 2023$1,541,116
-65.3%
790,316
-50.5%
0.00%
Q1 2023$4,439,730
+62.8%
1,597,026
+102.0%
0.00%
Q4 2022$2,727,059
+79.2%
790,452
+33.5%
0.00%
Q3 2022$1,522,000
+6.1%
592,210
-0.1%
0.00%
Q2 2022$1,434,000
+149.8%
592,606
+325.4%
0.00%
Q1 2022$574,000
-97.8%
139,304
-93.3%
0.00%
-100.0%
Q4 2021$26,596,000
-19.3%
2,068,151
-32.2%
0.00%
-33.3%
Q3 2021$32,959,000
+29.1%
3,051,858
+9.2%
0.00%
+50.0%
Q2 2021$25,522,000
-4.0%
2,795,413
-0.8%
0.00%0.0%
Q1 2021$26,575,000
+134.9%
2,818,107
-1.8%
0.00%
+100.0%
Q4 2020$11,312,000
+74.9%
2,870,984
+17.7%
0.00%0.0%
Q3 2020$6,466,000
-74.6%
2,439,866
-36.5%
0.00%
-66.7%
Q2 2020$25,498,000
-16.4%
3,840,170
-26.8%
0.00%
-25.0%
Q1 2020$30,516,000
-36.7%
5,243,071
-2.4%
0.00%
-20.0%
Q4 2019$48,177,000
+4.0%
5,370,923
+0.1%
0.01%
-16.7%
Q3 2019$46,335,000
-22.4%
5,366,039
+0.2%
0.01%
-14.3%
Q2 2019$59,686,000
+53.7%
5,357,830
+83.5%
0.01%
+40.0%
Q1 2019$38,827,000
-13.5%
2,919,381
+0.5%
0.01%
-16.7%
Q4 2018$44,864,000
+90.9%
2,903,830
+76.0%
0.01%
+100.0%
Q3 2018$23,496,0001,650,0000.00%
Other shareholders
GRITSTONE ONCOLOGY INC shareholders Q3 2021
NameSharesValueWeighting ↓
Versant Venture Management, LLC 4,450,638$41,970,0008.18%
Copernicus Capital Management, LLC 37,000$349,0005.64%
EcoR1 Capital, LLC 3,421,287$32,263,0001.43%
Palo Alto Investors LP 2,298,382$21,674,0001.24%
AlpInvest Partners B.V. 226,866$2,139,0001.06%
Stenahm Asset Managment Ltd 150,000$1,415,0001.00%
FRAZIER MANAGEMENT LLC 1,030,878$9,721,0000.78%
BVF INC/IL 1,861,239$17,551,0000.66%
Avidity Partners Management LP 2,122,064$20,011,0000.55%
Redmile Group, LLC 2,448,158$23,086,0000.32%
View complete list of GRITSTONE ONCOLOGY INC shareholders